Falsely Low Results Lead FDA To Affix Class I Designation To Recall Of Magellan Lead Tests
Executive Summary
The LeadCare II, LeadCare Plus and LeadCare Ultra Blood Lead Tests made by Magellan Diagnostics Inc. were recalled because falsely low results could cause health risks to children and pregnant people.